The option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma.

CONCLUSIONS: Option value is important when valuing therapies like nivolumab that extend life in a rapidly evolving area of care. PMID: 29087638 [PubMed - in process]
Source: The American Journal of Managed Care - Category: Health Management Authors: Tags: Am J Manag Care Source Type: research